The FDA approves INCY's Monjuvi in combination with rituximab and lenalidomide for relapsed/refractory follicular lymphoma, its second approved indication.

Following a complete response letter issued last October over CMC issues, CSL Behring LLC gained U.S. FDA approval June 16 of its humanized anti-factor XIIa monoclonal antibody, garadacimab (CSL-312), ...

Creative Biolabs recently rolled out a three-dimensional upgrade designed to make antibodies safer, more potent, and easier to develop. SHIRLEY, NY, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- ...

Thus, TACI is a promising target for SLE treatment. Methods In this study, we discovered a novel anti-TACI antibody, GenSci-X002, by hybridoma and humanization approach to investigate its funtion on ...

Both small animal models and microphysiological systems gain in sophistication and value as they expedite in vivo preclinical testing.

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

Study reveals the advantages and pitfalls of adding a TKI to a monoclonal antibody after chemoradiation for non-small cell ...

1 Lundbeck Seattle BioPharmaceuticals, Inc., Bothell, WA, United States 2 Alder BioPharmaceuticals, Inc. (CKA Lundbeck Seattle BioPharmaceuticals, Inc.), Bothell, WA ...